FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC

BSE6525.9560.55 (+0.94 %)

PREV CLOSE (Rs.) 6465.40

OPEN PRICE (Rs.) 6466.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 885

TODAY'S LOW / HIGH (Rs.)6450.45 6550.00

52 WK LOW / HIGH (Rs.)4912.3 6700

NSE6528.0063 (+0.97 %)

PREV CLOSE( Rs. ) 6465.00

OPEN PRICE (Rs.) 6505.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 6528.00 (8)

VOLUME 7452

TODAY'S LOW / HIGH(Rs.) 6451.00 6560.00

52 WK LOW / HIGH (Rs.)4863 6739

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

57.50

Dividend Yield(%)

1.92

TTM EPS (Rs.)

181.09

P/E Ratio

36.04

Book Value (Rs.)

360.40

Face Value (Rs.)

MCap (Rs. in Mn)

108326.74

Price/Earning (TTM)

33.57

Price/Sales (TTM)

8.51

Price/Book (MRQ)

18.11

PAT Margin (%)

22.78

ROCE (%)

58.05

Incorporation Year : 26-04 1967

Management Info :

S Madhavan - Chairman Milind Thatte - Managing Director

Registered Office :

Address : Ground Floor And First Floor P & G Plaza,Cardinal Gracias Road,Chakala, Andheri (East),
Mumbai,
Maharashtra-400099

Phone : 022 68669000

Email : investorgrievance.im@pg.com

Website : www.pghealthindia.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

26Aug Procter & Gamble Health re-submits an
With reference to its earlier communication dated August 6, 2025, Procte..

06Aug Procter & Gamble Health informs about
Procter & Gamble Health has informed that it enclosed the Business R..

06Aug Procter & Gamble Health informs about
Procter & Gamble Health has informed that it enclosed the Annual Rep..

Financials

	QTR Jun 25	ANNUAL 24
Net Profit	661.8	2009.8
Gross Profit	888.1	2733.2
Operating Profit	943.7	3216.3
Net Sales	3387.4	11512.6

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Cohance Lifesciences (BSE)

1011.20 (9.54%)

M.Cap (Rs. in Cr)38685.19

Glaxosmithkline Phar (BSE)

2820.85 (1.82%)

M.Cap (Rs. in Cr)47786.90

Haleos Labs (BSE)

1165.65 (4.22%)

M.Cap (Rs. in Cr)352.41

Caplin Point Lab (BSE)

2176.05 (1.86%)

M.Cap (Rs. in Cr)16540.53

Shareholding Pattern

	PROMOTERS	51.82%
	NON-INSTITUTION	27.03%
	MUTUAL FUNDS/UTI	10.65%
	FI/BANKS/INSURANCE	3.35%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

UTI MNC Fund-Reg(IDCW)

4.94

UTI Healthcare Fund...

4.30

Sundaram LT Tax Adv...

3.15

DSP Healthcare Fund...

3.06

Sundaram LT Tax Adv...

2.94

Sundaram LT Micro C...

2.91

Sundaram LT Micro C...

2.82

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

PROCTER & GAMBLE HEALTH LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives